Revolution Medicines Inc RVMD shares are trading lower by 8.77% to $24.18 Thursday morning after the company announced a $300 million offering of common stock.
See Also: Here's Why FuelCell Shares Are Falling
What Else?
In addition, Revolution Medicines intends to grant the underwriters a 30-day option to purchase up to an additional $45 million of shares of common stock.
Revolution Medicines says the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
According to data from Benzinga Pro, RVMD has a 52-week high of $31.37 and a 52-week low of $14.08.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.